News
TMO
577.39
+0.49%
2.80
THERMO FISHER SCIENTIFIC INC <TMO.N>: TD COWEN RAISES TARGET PRICE TO $648 FROM $644
Reuters · 5h ago
THERMO FISHER SCIENTIFIC INC <TMO.N>: JP MORGAN RAISES TARGET PRICE TO $650 FROM $600
Reuters · 6h ago
Thermo Fisher Scientific (TMO) Q1 2024 Earnings Call Transcript
Thermo Fisher Scientific's (TMO) first quarter 2024 earnings call is being webcast live. The company's chairman, president and chief executive officer, Marc Casper, will discuss the company's financial results. The conference call will also include a forward-looking statement. Thermo Fisher's first quarter revenue was $10.34 billion.
The Motley Fool · 15h ago
Thermo Fisher (TMO) Q1 Earnings Top Estimates, 2024 View Up
NASDAQ · 15h ago
Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday?
The S&P 500 fell 0.4% in midday trading in New York. The yield on the 30-year Treasury bond has surged to 4.79%, the highest level since early November. The Japanese yen tumbled to the lowest level since June 1990. Tesla Inc. Posted lower-than-expected results last quarter, but shares rose 10%.
Benzinga · 16h ago
THERMO FISHER SCIENTIFIC INC <TMO.N>: EVERCORE ISI RAISES TARGET PRICE TO $615 FROM $610
Reuters · 19h ago
TMO Stock Earnings: Thermo Fisher Scientific Beats EPS, Beats Revenue for Q1 2024
Thermo Fisher Scientific just reported results for the first quarter of 2024. The company reported earnings per share of $5.11 and revenue of $10.35 billion. This was above the analyst estimate of $4.71 for the same period. The stock is up 1.7% today.
Investorplace · 19h ago
Durable Goods Orders Came In Line With Expectations
NASDAQ · 19h ago
Thermo Fisher Lifts Annual Forecast On Improved Demand, Despite Q1 Revenue Dip
Thermo Fisher Scientific posted a first-quarter revenue of $10.34 billion, down 3% year over year. The company beat the consensus estimate. Thermo Fisher raises its 2024 sales guidance to $42.3 billion. The firm also raised its adjusted EPS guidance for the year.
Benzinga · 19h ago
Boeing Mixed in Q1, TMO Beats; Durable Goods In-Line
NASDAQ · 19h ago
Thermo Fisher Scientific Inc reports results for the quarter ended in March - Earnings Summary
Thermo Fisher Scientific Inc reports quarterly adjusted earnings of $5.11 per share for the quarter ended in March. Revenue fell 3.4% to $10.35 billion from the same quarter last year. The company reported quarterly income of $1.33 billion.
Reuters · 20h ago
Compared to Estimates, Thermo Fisher (TMO) Q1 Earnings: A Look at Key Metrics
NASDAQ · 20h ago
BUZZ-Thermo Fisher rises on Q1 profit beat, raises annual profit forecast
Shares of medical equipment maker Thermo Fisher Scientific rise 1.5% to $583 premarket. Co posts Q1 profit beat, raises annual profit forecast to $21.14-$22.02. Company posted Q1 revenue of $10.35 bln.
Reuters · 21h ago
Thermo Fisher Scientific Q1 24 Earnings Conference Call At 8:30 AM ET
NASDAQ · 22h ago
Thermo Fisher lifts profit forecast as medical equipment demand improves
Thermo Fisher lifts profit forecast as medical equipment demand improves. Firm beat Wall Street estimates for quarterly profit and raised its annual profit forecast. The medical equipment maker's shares up about 4% premarket. Firm expects annual adjusted profit of $21.14 to $22.02 per share.
Reuters · 23h ago
THERMO FISHER SHARES UP 3.5% PREMARKET AFTER CO RAISES 2024 PROFIT FORECAST
Reuters · 23h ago
Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally
Nasdaq and S&P 500 futures signal a higher open on Wednesday. Tesla, Inc. And Texas Instruments provide upbeat guidance. Dow Jones Industrial Average climbs for a fourth straight session to a two-week high. Weak private-sector activity data on Tuesday could keep the Fed dovish.
Benzinga · 23h ago
Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching
Thermo Fisher Scientific Inc. Is trading around the price of US$575. The company's stock is expected to grow by 39% over the next few years. The stock is currently trading around its industry peers' price multiples. The future growth potential of the company appears to have been factored into the current share price. Is the company currently undervalued? We look at Thermo Fisher scientific to see if it's a good investment.
Simply Wall St · 23h ago
Thermo Fisher Scientific 1Q Revenue Tops Estimates, Raises 2024 Outlook
Thermo Fisher Scientific posted better-than-expected revenue in its first quarter. The scientific-equipment company logged net income of $1.33 billion for the first quarter ended March 30. The company raised its outlook for 2024 to $43.3 billion. It said the increase reflects stronger operational performance.
Dow Jones · 23h ago
More
Webull provides a variety of real-time TMO stock news. You can receive the latest news about Thermo Fishr Sci through multiple platforms. This information may help you make smarter investment decisions.
About TMO
Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. The Company's Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.